Skip to main content
. Author manuscript; available in PMC: 2025 Mar 15.
Published in final edited form as: ACS Infect Dis. 2025 Feb 14;11(3):689–702. doi: 10.1021/acsinfecdis.4c00768

Table 2.

In vitro inhibition (apparent IC50) of bacterial DHFR by select DADHTs.

Compound EcDHFR
IC50 (μM ± SD)
SaDHFR
IC50 (μM ± SD)
CYC 23 ± 16 nfa
1d 3 ± 1 ntb
1e 1.0 ± 0.3 2.5 ± 0.5
1f 5 ± 2 nt
2f 26 ± 9 14 ± 5
3c 3 ± 1 nt
3d 5 ± 3 1.7 ± 0.3
3e 2.1 ± 0.2 0.9 ± 0.3
5 7 ± 5 23 ± 14
TMP 9.9 × 10−3 ± 7 × 10−3 3.3 × 10−3 ± 7 × 10−4
a

nf = no fit to the data due to partial inhibition, see Figure S17 and S18.

b

nt = not tested.